JP2018535678A5 - - Google Patents

Download PDF

Info

Publication number
JP2018535678A5
JP2018535678A5 JP2018526505A JP2018526505A JP2018535678A5 JP 2018535678 A5 JP2018535678 A5 JP 2018535678A5 JP 2018526505 A JP2018526505 A JP 2018526505A JP 2018526505 A JP2018526505 A JP 2018526505A JP 2018535678 A5 JP2018535678 A5 JP 2018535678A5
Authority
JP
Japan
Prior art keywords
promoter
phenylalanine
gene
pal
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018535678A (ja
JP6993970B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2016/032562 external-priority patent/WO2016183531A1/en
Application filed filed Critical
Priority claimed from PCT/US2016/062369 external-priority patent/WO2017087580A1/en
Publication of JP2018535678A publication Critical patent/JP2018535678A/ja
Publication of JP2018535678A5 publication Critical patent/JP2018535678A5/ja
Priority to JP2021200761A priority Critical patent/JP7245312B2/ja
Application granted granted Critical
Publication of JP6993970B2 publication Critical patent/JP6993970B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526505A 2015-11-16 2016-11-16 高フェニルアラニン血症を低減させるように操作された細菌 Active JP6993970B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021200761A JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562256052P 2015-11-16 2015-11-16
US62/256,052 2015-11-16
USPCT/US2016/032562 2016-05-13
PCT/US2016/032562 WO2016183531A1 (en) 2015-05-13 2016-05-13 Bacteria engineered to reduce hyperphenylalaninemia
PCT/US2016/062369 WO2017087580A1 (en) 2015-11-16 2016-11-16 Bacteria engineered to reduce hyperphenylalaninemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021200761A Division JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌

Publications (3)

Publication Number Publication Date
JP2018535678A JP2018535678A (ja) 2018-12-06
JP2018535678A5 true JP2018535678A5 (cg-RX-API-DMAC7.html) 2020-01-09
JP6993970B2 JP6993970B2 (ja) 2022-02-15

Family

ID=58717781

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2018526505A Active JP6993970B2 (ja) 2015-11-16 2016-11-16 高フェニルアラニン血症を低減させるように操作された細菌
JP2021200761A Active JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2023037499A Active JP7494345B2 (ja) 2015-11-16 2023-03-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2024083082A Active JP7813312B2 (ja) 2015-11-16 2024-05-22 高フェニルアラニン血症を低減させるように操作された細菌
JP2026013804A Pending JP2026086510A (ja) 2015-11-16 2026-01-30 高フェニルアラニン血症を低減させるように操作された細菌

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2021200761A Active JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2023037499A Active JP7494345B2 (ja) 2015-11-16 2023-03-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2024083082A Active JP7813312B2 (ja) 2015-11-16 2024-05-22 高フェニルアラニン血症を低減させるように操作された細菌
JP2026013804A Pending JP2026086510A (ja) 2015-11-16 2026-01-30 高フェニルアラニン血症を低減させるように操作された細菌

Country Status (7)

Country Link
US (2) US11618894B2 (cg-RX-API-DMAC7.html)
EP (2) EP3377518B1 (cg-RX-API-DMAC7.html)
JP (5) JP6993970B2 (cg-RX-API-DMAC7.html)
AU (3) AU2016356684C1 (cg-RX-API-DMAC7.html)
ES (1) ES2925049T3 (cg-RX-API-DMAC7.html)
PL (1) PL3377518T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017087580A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3882259B1 (en) 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
JP6993970B2 (ja) * 2015-11-16 2022-02-15 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を低減させるように操作された細菌
EP3642221A1 (en) 2017-06-21 2020-04-29 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
KR20220003030A (ko) 2019-04-29 2022-01-07 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
CA3142608A1 (en) 2019-06-04 2020-12-10 Cocoon Biotech Inc. Silk-based products, formulations, and methods of use
EP3999071A1 (en) * 2019-07-15 2022-05-25 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for predicting and treating cardiac dysfunction
CN110643585B (zh) * 2019-11-08 2021-09-03 江南大学 一种利用氨基酸脱氨酶生产α-酮-β-甲基正戊酸的方法
CN113493796B (zh) * 2020-03-18 2023-05-30 苏州优信合生技术有限公司 苯丙酮尿症治疗用益生菌工程菌株的构建方法与应用
WO2021188819A1 (en) 2020-03-20 2021-09-23 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
CN113755516B (zh) * 2020-06-05 2026-03-20 中国医学科学院药物研究所 工程粪肠球菌在治疗苯丙酮尿症药物中的应用
US20220031771A1 (en) * 2020-07-31 2022-02-03 Iowa State University Research Foundation, Inc. Microencapsulated and chromosome integrated compositions for l-dopa microbiome therapy
AU2021393455A1 (en) 2020-12-02 2023-06-29 Synlogic Operating Company, Inc. Engineered microorganisms
CN112662607B (zh) * 2021-01-07 2026-07-17 上海陶宇晟生物技术有限责任公司 具备表面展示苯丙氨酸解氨酶的工程益生菌
WO2023044479A1 (en) * 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
CN113969292B (zh) * 2021-11-15 2023-07-07 山东第一医科大学(山东省医学科学院) 治疗苯丙酮尿症的工程益生菌及其构建方法与应用
WO2026163257A1 (en) 2025-01-29 2026-08-06 Dr. Schär S.P.A. Microorganism, production method and use for the treatment of phenylketonuria

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
CN1154845A (zh) * 1996-09-09 1997-07-23 首都医学院附属北京红十字朝阳医院 能表达活性苯丙氨酸脱氨酶的基因工程菌口服制剂
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
CA2353800A1 (en) 1998-12-02 2000-06-08 Trustees Of Boston University Gene networks for control of gene expression
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2446776C (en) 2001-05-03 2011-07-12 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Self-containing lactococcus strain
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US7731976B2 (en) 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
JP4452914B2 (ja) 2003-09-08 2010-04-21 味の素株式会社 新規トランスポータタンパク質
WO2006069610A2 (en) * 2004-07-02 2006-07-06 Metanomics Gmbh Process for the production of fine chemicals
GB0501540D0 (en) 2005-01-25 2005-03-02 Univ Leeds Controlled production and delivery of biologically active agents by gut bacteria
EP1869174B1 (en) * 2005-03-10 2015-02-18 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
EP2029739A4 (en) * 2006-06-02 2009-11-25 Verenium Corp LYASE ENZYMES, NUCLEIC ACIDS FOR THEIR CODING AND METHOD FOR THEIR PREPARATION AND USE
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
US20100297249A1 (en) * 2007-07-05 2010-11-25 North-West University Enhancement of the efficacy of therapeutic proteins
CN101586111B (zh) 2008-05-22 2012-03-07 北京三元基因工程有限公司 一种活性乳酸乳球菌制品的制备方法
JP2012504116A (ja) 2008-09-29 2012-02-16 アクトジェニックス・エヌブイ 粘膜での微生物のコロニー形成の低減
RU2603061C2 (ru) 2010-03-02 2016-11-20 Ренессанс Байосайенс Корп., Функциональное улучшение микроорганизмов для минимизации продукции акриламида
US8129170B1 (en) 2010-12-06 2012-03-06 E.I. Du Pont De Nemours And Company Recombinant bacteria having the ability to metabolize sucrose
US9409950B2 (en) 2010-12-23 2016-08-09 Biogen Ma Inc. Linker peptides and polypeptides comprising same
US9017961B2 (en) 2012-03-05 2015-04-28 E.I. Du Pont De Nemours And Company Recombinant bacteria comprising novel sucrose transporters
FR2990699B1 (fr) 2012-05-21 2016-02-05 Agronomique Inst Nat Rech Cassettes d'expression procaryotes regulees par le stress
US20150337336A1 (en) * 2012-06-22 2015-11-26 Phytogene, Inc. Enzymes and methods for styrene synthesis
EP3222288A1 (en) * 2012-07-27 2017-09-27 University of North Texas Genetically modified probiotic for the treatment of phenylketonuria (pku) disease
EP2914274A4 (en) * 2012-11-01 2016-07-20 Sydney Children S Hospital Network Randwick And Westmead GENETICALLY MODIFIED PROBIOTIC FOR THE TREATMENT OF PHENYLKETONURIA
JP6419082B2 (ja) 2012-12-13 2018-11-07 マサチューセッツ インスティテュート オブ テクノロジー リコンビナーゼに基づく論理/メモリシステム
US9951340B2 (en) 2013-03-07 2018-04-24 The General Hospital Corporation Compositions and methods for bacterial delivery of polypeptides
US9688967B2 (en) * 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
EP3882259B1 (en) * 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
EP3294757B1 (en) 2015-05-13 2023-12-27 Synlogic Operating Company, Inc. Bacteria engineered to treat a disease or disorder
EP3307870B1 (en) * 2015-06-10 2023-08-02 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
US20170216370A1 (en) * 2015-07-31 2017-08-03 Synlogic, Inc. Bacteria engineered to treat disorders involving propionate catabolism
JP6993970B2 (ja) * 2015-11-16 2022-02-15 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を低減させるように操作された細菌
EP3606544B1 (en) * 2017-04-05 2025-06-04 University of Massachusetts Minigene therapy
SK289101B6 (sk) * 2020-12-17 2023-08-09 Ústav molekulárnej biológie Slovenskej akadémie vied, verejná výskumná inštitúcia Antimikrobiálny proteín, antimikrobiálny rekombinantný proteín s lytickými vlastnosťami, expresný vektor, spôsob ich prípravy a použitie

Similar Documents

Publication Publication Date Title
JP7245271B2 (ja) 高フェニルアラニン血症を低減させるように操作された細菌
JP7494345B2 (ja) 高フェニルアラニン血症を低減させるように操作された細菌
JP2020525012A (ja) 障害の処置のための細菌
HK40085223A (en) Bacteria engineered to reduce hyperphenylalaninemia
CA3005451C (en) Bacteria engineered to reduce hyperphenylalaninemia